About
Passage Bio Inc (NASDAQ:PASG) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 20 2026
Passage Bio Reports Updated Interim Data from upliFT-D Trial and Provides Regulatory and Corporate Updates
Mar 3 2026
Passage Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Recent Business Highlights
Nov 10 2025
Passage Bio Reports Third Quarter 2025 Financial Results and Provides Recent Business Highlights
Nov 5 2025
Passage Bio to Present at Guggenheim Securities 2nd Annual Healthcare Innovation Conference
Oct 14 2025
Passage Bio to Participate in Chardan’s 9th Annual Genetic Medicines Conference
Financials
Revenue
$0
Market Cap
$28.1 M
EPS
-14.35
Translate